Home > Healthcare > Medical Devices > Therapeutic Devices > Stoma Care Market

Stoma Care Market Size - By Product Type (Ostomy Bags {One-piece Bags, Two-piece Bags}, Accessories), By Surgery Type (Colostomy, Ileostomy, Urostomy), By End-use (Hospitals and Specialty Clinics, ASCs, Home Care Settings) & Forecat, 2023 – 2032

  • Report ID: GMI6484
  • Published Date: Aug 2023
  • Report Format: PDF

Stoma Care Market Size

Stoma Care Market size was valued at around USD 3.2 billion in 2022 and is projected to reach over USD 5.2 billion by 2032. This incremental growth rate is owing to increasing prevalence of chronic diseases including inflammatory bowel diseases and colorectal cancer coupled with rising demand for minimally invasive surgical procedures for the diagnosis and treatment of these ailments.
 

Stoma Care Market

Technological advancements in stoma care products associated with rising awareness and favorable reimbursement scenario is anticipated to drive the market growth. Stoma care encompasses a range of products intended to improve the quality of life for individuals with stomas.
 

The stoma care industry's growth is influenced by factors such as the aging population, increasing prevalence of stoma-related conditions, advancements in medical technology, and improved awareness and acceptance of ostomy care. Innovations in stoma appliances and accessories focus on improving wearability, reducing leakage, enhancing comfort, and ensuring discreetness for patients. Improvements in stoma care products directly impact the quality of life for patients, making this a critical consideration for both manufacturers and healthcare providers. Affordability and insurance coverage for stoma care products can impact patient access and market dynamics.
 

Stoma care devices are specialized medical products and equipment intended to support individuals who have undergone ostomy surgery. These devices are designed to collect waste, protect the skin around the stoma, and promote effective stoma management securely and comfortably.
 

However, discomfort and risk of skin irritation and infections can pose a significant challenge and impede the market progress. Individuals with stomas often experience discomfort due to the presence of the stoma and the use of stoma care devices. The skin around the stoma is particularly vulnerable to irritation and infections. Adhesive materials used in stoma care devices, if not properly managed, can lead to skin reactions, redness, itching, and breakdown. Additionally, the accumulation of moisture, digestive enzymes, or urine in the area can create an environment conducive to bacterial or fungal growth, increasing the risk of infections. These challenges can have a direct impact on patients' willingness to adhere to their stoma care regimen and use stoma care products effectively. Skin irritation and infections can further exacerbate discomfort and decrease patients' overall satisfaction with their stoma care routine.
 

COVID-19 Impact

The recent outbreak of COVID-19 had a negative impact that influenced the stoma care market revenue, specifically during the initial phase of 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during the pandemic phase. These conditions impacted the market growth. Several hospitals and healthcare facilities globally experienced a significant decline in patient visits for diagnosis and treatment of inflammatory bowel diseases and other colorectal ailments, among others.
 

The COVID-19 pandemic reduced visits to healthcare facilities, causing medical services in several countries to be delayed, including minimally invasive procedures. The pandemic led to disruptions in global supply chains, affecting the production and distribution of medical devices, including stoma care products. Lockdowns, travel restrictions, and manufacturing shutdowns disrupted the flow of raw materials, components, and finished products. This resulted in delays in manufacturing, reduced product availability, and increased lead times, affecting healthcare facilities' ability to procure stoma care devices.
 

Many elective surgeries, including some ostomy surgeries, were postponed or canceled to prioritize COVID-19 patients and reduce the risk of virus transmission. This led to a decrease in the number of new ostomy patients, resulting in a lower demand for stoma care devices during the pandemic. Thus, the COVID-19 pandemic had a negative impact on the market during 2020 which gained impetus in the later stages during 2021. Reducing COVID-19 infection rates and patients, as well as increased procedural volume, are expected to aid market expansion.
 

Stoma Care Market Trends

Increasing prevalence of inflammatory bowel diseases (IBD) is one of the significant factor that is anticipated to drive the market growth. Inflammatory bowel diseases refer to a group of chronic inflammatory conditions that primarily affect the gastrointestinal tract. These conditions can lead to severe symptoms and complications, often necessitating surgical interventions, including ostomy surgery. The global incidence of IBD has been steadily increasing over the years. For instance, according to the European Federation of Crohn's and Ulcerative Colitis Associations data, in 2022, around 10 million individuals globally were estimated to suffer from inflammatory bowel diseases. As more individuals are diagnosed with conditions such as Crohn's disease and ulcerative colitis, the demand for ostomy surgeries to manage these diseases is expected to increase significantly.
 

Ostomy surgery can provide relief from debilitating symptoms and improve patients' quality of life. As the number of individuals undergoing ostomy surgery increases, the demand for stoma care devices and related products. Ostomy surgery often results in a permanent or long-term stoma. Individuals who undergo ostomy surgery require ongoing stoma care and use stoma care devices, such as ostomy bags and skin barriers, to effectively manage their condition. This creates a continuous need for stoma care products throughout a patient's life. The increasing prevalence of IBD has driven research and innovation in stoma care technology. Manufacturers are developing advanced stoma care devices with features such as improved adhesives, odour control, and ergonomic designs. These innovations contribute to better patient outcomes and encourage market progress.
 

Stoma Care Market Analysis

Stoma Care Market Size, By Product Type

Based on product, the stoma care market is segmented as ostomy bags and accessories. The ostomy bags segment was valued at around USD 2.7 billion in 2022. This significant market share is owing to several benefits offered by ostomy bags in stoma surgery. Ostomy bags effectively contain bodily waste, minimizing the risk of leakage and maintaining good hygiene. These bags have built-in filters that help neutralize odours, providing confidence and comfort in social situations. Ostomy bags help protect the skin around the stoma from contact with waste, reducing the risk of surgical site infections.
 

Moreover, ostomy bags are available in a variety of options including one-piece and two-piece systems. The two-piece systems allow for separate attachment of the pouch and barrier providing protection between the skin and adhesive materials, reducing the risk of skin irritation. As the IBD procedure continues to increase, the demand for specialized ostomy bags that facilitate these procedures also increases. These bags allow for enhanced quality of life for the patients by providing a convenient and discreet way to manage waste elimination without the need for constant proximity to a restroom.
 

Based on surgery, the stoma care market is segmented as colostomy, ileostomy, and urostomy. The colostomy surgery segment was valued at around USD 1.5 billion in 2022. This significant market share is attributable to the rising geriatric population and increases in the risk of colorectal cancer cases. According to Who data, in 2020, around 1.8 million people globally were diagnosed with colorectal cancer worldwide accounting for around 1.1 million colon cancer cases and 0.7 million rectal cancer cases. This rising prevalence of colorectal cancer and other chronic ailments increases the demand for colostomy bags.
 

Furthermore, the increasing geriatric population is more prone to colon cancer and other diseases, that is further accelerating the need for colostomy surgeries. According to Union for International Cancer Control 2023, people aged 65 years and above are 11 times more likely to develop colorectal cancer as compared to younger people. Cancer in elderly people and colostomy treatment procedures will continue to grow over the projected period and is expected to contribute to the segment growth.
 

Stoma Care Market Revenue Share, By End-use,

Based on end-use, the stoma care market is segmented into hospitals and specialty clinics, ambulatory surgical centers (ASCs), and home care settings. The home care settings segment is projected to reach around USD 2.6 billion by 2032. This majority market share is owing to the soaring demand for home healthcare, enhanced comfort and flexibility thereby surging the patient preference for home care settings. Patients who have undergone stoma surgeries often require stoma care over a long duration of time. The majority of people choose to recover at home rather than in hospitals or clinics. Advancements in telemedicine and digital health technologies enable healthcare providers to remotely monitor and guide patients in stoma care management. Patients can receive real-time guidance and support from healthcare professionals without leaving their homes.
 

Home care allows for more personalized stoma care. Patients receive one-on-one attention and can actively participate in their care plan, leading to better outcomes. The increasing preference for home care settings for stoma care aligns with the broader trend of patient-centred care and can lead to improved patient outcomes, increased patient satisfaction, and more efficient healthcare delivery. Additionally, less cost associated with home care settings is estimated to boost demand, thereby propelling the segment revenue.
 

North America Stoma Care Market Size,

North America region held a substantial share in the global stoma care market and was valued at over USD 646 million in 2022. This high market share is ascribed to a variety of factors, including the presence of significant industry players, an increase in the number of patients suffering from IBD, an expanding elderly population, among others. North America has a well-established healthcare infrastructure, a strong emphasis on technological advancements, and a high burden of chronic diseases, that drives the demand for stoma care. Increasing prevalence of inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis in the region is anticipated to drive the product adoption rate.
 

The aging population in North America is contributing to an increased demand for healthcare services, including stoma care. Older adults are more susceptible to conditions that may require ostomy surgery, and they require ongoing support and care to manage their stomas. North America has a well-developed healthcare infrastructure with access to advanced medical technologies and treatments. This includes a wide range of stoma care products and services that are readily available to patients, contributing to the demand for these products.
 

Stoma Care Market Share

Some of the major players operating in the stoma care market are :

  • Coloplast A/S
  • B Braun Melsungen AG
  • Hollister Inc.
  • ConvaTec Group Plc.
  • Salts Healthcare
  • Welland Medical Limited
  • Alcare Co.LTD
  • Nu-Hope Labs
  • Smith & Nephew
  • Flexicare Ltd.
  • Torbot Group Inc
  • Cymed Micro Skin
  • 3M Company

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
 

Stoma Care Industry Leaders:

  • In February 2022, Coloplast announced the launch of SenSura Mio, an ostomy product in Singapore. This product is incorporated with body fit technology, an elastic adhesive technology, that aims to improve the quality of life of ostomates. This innovative product launch helped the company to expand their geographic presence and enhance their business revenue.
     
  • In June 2021, Welland announced the launch of Aurum Plus, an advance ostomy pouch in several countries globally. The flange and body-hugging comfort curves helps to reduce the risk of the outlet twisting and blocking the flow of urine. This strategic product launch helped the company to increase their customer base and enhance their product portfolio.
     

Stoma care market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report


By Product Type, 2018 - 2032 (USD Million)

  • Ostomy Bags
    • One-piece bags
    • Two-piece bags
  • Accessories

By Surgery Type, 2018 - 2032 (USD Million)

  • Colostomy
  • Ileostomy
  • Urostomy
  • Total

By End-use, 2018 - 2032 (USD Million)

  • Hospitals and Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Poland
    • Sweden
    • The Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Egypt
    • Turkey

 

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Stoma care industry was valued at around USD 3.2 billion in 2022 and is projected to reach over USD 5.2 billion by 2032, owing to increasing prevalence of chronic diseases.

The colostomy surgery segment accounted for USD 1.5 billion in 2022 and will continue the growth through 2032, attributable to the rising geriatric population and increases in the risk of colorectal cancer cases.

North America stoma care market was valued at over USD 646 million in 2022 and will showcase strong growth over 2023-2032, ascribed to the increase in the number of patients suffering from IBD, and expanding elderly population.

Coloplast A/S, B Braun Melsungen AG, Hollister Inc., ConvaTec Group Plc., Salts Healthcare, Welland Medical Limited, Alcare Co., LTD, Nu-Hope Labs, Smith & Nephew, Flexicare Ltd., Torbot Group Inc., Cymed Micro Skin, 3M Company among others.

Stoma Care Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 344
  • Countries covered: 30
  • Pages: 190
 Download Free Sample